2Ferguson B, Gray SD. Time and dose effects of mitomycin C onextraeellular matrix fibroblasts and proteins [J]. Laryngoscope, 2005, 115 (1) : 110 - 115
3Rousseru B, Hirano S, Scheidt TD, et al. Characterization of vocal fold scarring in a canine model [J]. Laryngoscope,2003,113(4) :620 - 627
3Chung JH, Cosenza MJ, Rahbar R, et al. Mitomycin C for the prevention of adhesion formation after endoscopic sinus surgery: a randomized, controlled study. Otolaryngol Head Neck Surg, 2002, 126 (5) : 468-474.
4Huang TS, Topical mitomycin C and cephalosporin in endolymphatic sac surgery. Laryngoscope, 2002, 112 (2): 243-247.
5Yazawa Y, Suzuki M, Kitano H, et al. Intraoperative mitomycin C in endolymphatic sac surgery for Meniere' s disease:A pilot study. ORLJ Otorhinolaryngol Relat Spec, 1999, 61 (4) : 188-194.
6Estrem SA, Batra PS. Preventing myringotomy closure with topical mitomycin C in rats.Otolaryngol Head Neck Surg, 1999, 120 (6): 794-798.
7Jassir D, Buchman CA, Gomez-Marin O. Safety and efficacy of topic mitomycin C in myringotomy patency. Otolaryngol Head Neck Surg, 2001, 124 (4) : 368-373.
8D' eredita R. Contact diode laser myringotomy and mitomycin C in children. Otolaryngol Head Neck Surg, 2004, 130 (6): 742-746.
9Unal M. The successful management of congenital laryngeal web with endoscope lysis and topical mitomycin C. Int J Pediatr Otorhinolaryngol, 2004, 68 (2): 231-235.
10Hartnick CJ, Hartley BE, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial. Arch Otolaryngol Head Neck Surg, 2001, 127 (10) : 1260-1264.
2Dohar JE, Klein EC, Betsch JL, et al. Acquired subglottic stenosis-depth and not extent of the insult is key[ J]. Int J Pediatr Otorhinolaryngol, 1998,46 ( 3 ) : 159 - 170.
3Niessen FB, Spauwen PH, Schalkwijk J, et al. On the nature of hypertrophic scars and keloids: a review [ J ]. Plast Reconstr Surg, 1999,104 (5) : 1435 - 1458.
4Zur KB, Urken ML. Vascularized hemitracheal autograft for laryngotracheal reconstruction: a new surgical technique based on the thyroid gland as a vascular carrier[ J]. Laryngoscope, 2003,113 ( 9 ) : 1494 - 1498.
5Rahbar R, Shapshay SM, Healy GB. Mitomycin : effects on laryngeal and tracheal stenosis, benfits and complication [ J]. Ann Otol Rhinol Laryngol,2001,110( 1 ):1 -6.
6Eliashar R, Gross M, Maly B, eta. Mitomycin does not prevent laryngotracheal repeat stenosis after endoscopic dilation surgery : an animal study[ J]. Laryngoscope ,2004,114 (4) :743 -746.
7Hartnick C J, Martley BE, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction: a randomized, double-blind, placebo-controlled trial [ J ]. Arch Otolaryngol Head Neck Surg,2001,127 (10) : 1260 - 1264.
8Mandour M, Remacle M,Van de Heyning P, et al. Chronic subglottic and tracheal stenosis: endoscopic management vs. surgical reconstruction[ J]. Eur Arch Otorhinolaryngol, 2003,260(7) :374 - 380.
9Watters K, Russell J. Subglottic stenosis in Wegeners granulomatosis and the nitinol stent [ J ]. Laryngoscope, 2003,113 (12) :2222 - 2224.
